Home
Products
Gene
mRNA Products
mRNAs for Cancer Vaccine Research
mRNAs for Cancer Vaccine Research

mRNAs for Cancer Vaccine Research

Seattle Genova is one of the leading providers of life sciences products, offering a wide range of products, including mRNA services. Advancement in therapeutic medicine, mRNA has remarkably outcast everything to solve puzzles in the research field. With the increasing demand for mRNA and the help of Ph.D. experts, Seattle Genova has succeeded in developing services on mRNAs for cancer vaccine research. We provide high-quality cost-friendly products to meet our customer’s needs. Seattle Genova offers antibodies, bioactive proteins, virus particles, mRNA products, Stable cell lines, and research use kits in this category.  

Compare
Catalog Number
Gene Name
Product Name
More
EPCAM (GA733)
EPCAM (GA733) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0101
EPCAM (GA733) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding EPCAM (GA733) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0101-LNP
EPCAM (GA733) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
ERBB2
ERBB2 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0102
ERBB2 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding ERBB2 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0102-LNP
ERBB2 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
H2-K1
H2-K1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0103
H2-K1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding H2-K1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0103-LNP
H2-K1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Cd40lg
Cd40lg Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0104
Cd40lg Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding Cd40lg was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0104-LNP
Cd40lg Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CEACAM5 (CEA)
CEACAM5 (CEA) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0105
CEACAM5 (CEA) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CEACAM5 (CEA) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0105-LNP
CEACAM5 (CEA) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
TERT
TERT Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0106
TERT Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding TERT was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0106-LNP
TERT Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
NY-ESO-1
NY-ESO-1 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0107
NY-ESO-1 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding NY-ESO-1 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0107-LNP
NY-ESO-1 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
HPV16 E7
HPV16 E7 Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0108
HPV16 E7 Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding HPV16 E7 was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0108-LNP
HPV16 E7 Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
VEGFA
VEGFA Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0109
VEGFA Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding VEGFA was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0109-LNP
VEGFA Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
CAP-2 (CEA Peptide 9-mer)
CAP-2 (CEA Peptide 9-mer) Circular RNA for Cancer Vaccine Research
Expand
SKU
Product_name
Product Description
CVAC-ORNA-0110
CAP-2 (CEA Peptide 9-mer) Circular RNA for Cancer Vaccine Research
In Vitro Transcribed mRNA template encoding CAP-2 (CEA Peptide 9-mer) was further circularized with Seattle Genova's OSTAR technology. The resulting circRNAs are very stable and have low immunogenicity enabling prolonged protein translation in different cells without cellular toxicity.
CVAC-ORNA-0110-LNP
CAP-2 (CEA Peptide 9-mer) Circular RNA-LNP for Cancer Vaccine Research
ALG-ORNA-0001 was encapsulated with lipid nanoparticles through Seattle Genova's LipoX platform.
Choose up to 4 products to compare
Compare
Clear All
0.250499s